Idelalisib in Relapsed or Refractory Follicular Lymphoma

Idelalisib in Relapsed or Refractory Follicular Lymphoma

User Photo
obr

7 months
18 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David Andorsky, MD Medical Oncologist, Associate Chair, US Oncology Research Group, Rocky Mountain Cancer Centers shares the results and findings for idelalisib in patients with relapsed or refractory follicular lymphoma.
Up Next Autoplay